🇺🇸 anti-d in United States

261 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Foetal Exposure During Pregnancy — 40 reports (15.33%)
  2. Premature Baby — 32 reports (12.26%)
  3. Thrombocytopenia — 27 reports (10.34%)
  4. Atrial Septal Defect — 26 reports (9.96%)
  5. Haemorrhage — 26 reports (9.96%)
  6. Platelet Count Increased — 24 reports (9.2%)
  7. Alanine Aminotransferase Increased — 23 reports (8.81%)
  8. Arthralgia — 22 reports (8.43%)
  9. Rash Erythematous — 21 reports (8.05%)
  10. Congenital Anomaly — 20 reports (7.66%)

Source database →

anti-d in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is anti-d approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for anti-d in United States?

Post Graduate Institute of Medical Education and Research, Chandigarh is the originator. The local marketing authorisation holder may differ — check the official source linked above.